HEADER SERINE PROTEASE INHIBITOR 11-JUN-96 1PSI TITLE INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA=1=-ANTITRYPSIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD PLASMA; SOURCE 7 GENE: ALPHA-1-ANTITRYPSIN; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PTERMAT; SOURCE 11 EXPRESSION_SYSTEM_GENE: ALPHA-1-ANTITRYPSIN KEYWDS SERPIN, SERINE PROTEASE INHIBITOR, GLYCOPROTEIN, POLYMORPHISM, KEYWDS 2 EMPHYSEMA, DISEASE MUTATION, ACUTE PHASE EXPDTA X-RAY DIFFRACTION AUTHOR J.P.ABRAHAMS,P.R.ELLIOTT,D.A.LOMAS,R.W.CARRELL REVDAT 5 09-AUG-23 1PSI 1 REMARK REVDAT 4 03-NOV-21 1PSI 1 SEQADV SHEET LINK REVDAT 3 31-MAR-10 1PSI 1 REMARK REVDAT 2 24-FEB-09 1PSI 1 VERSN REVDAT 1 07-DEC-96 1PSI 0 JRNL AUTH P.R.ELLIOTT,D.A.LOMAS,R.W.CARRELL,J.P.ABRAHAMS JRNL TITL INHIBITORY CONFORMATION OF THE REACTIVE LOOP OF ALPHA JRNL TITL 2 1-ANTITRYPSIN. JRNL REF NAT.STRUCT.BIOL. V. 3 676 1996 JRNL REFN ISSN 1072-8368 JRNL PMID 8756325 JRNL DOI 10.1038/NSB0896-676 REMARK 2 REMARK 2 RESOLUTION. 2.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 6699 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2956 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.530 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 15.76 REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES 106 - 108 ARE POORLY ORDERED. ALTHOUGH SOME REMARK 3 CONNECTED DENSITY EXISTS, A STEREOCHEMICALLY CORRECT REMARK 3 MODEL FITTING THE DATA COULD NOT BE BUILT. THE REMARK 3 OCCUPANCIES OF THESE RESIDUES ARE SET TO ZERO. REMARK 3 REMARK 3 PRO 106 - SER 108 IS A POORLY ORDERED LOOP, PRESENT IN REMARK 3 MULTIPLE CONFORMATIONS. A STEREOCHEMICALLY VALID MODEL WAS REMARK 3 BUILT, BUT THE OCCUPANCIES ARE SET TO ZERO. REMARK 4 REMARK 4 1PSI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175826. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-96 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ELLIOTT GX-11 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NICKEL COATED DOUBLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7651 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.920 REMARK 200 RESOLUTION RANGE LOW (A) : 19.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.11400 REMARK 200 R SYM (I) : 0.11400 REMARK 200 FOR THE DATA SET : 8.3600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.20400 REMARK 200 R SYM FOR SHELL (I) : 0.20400 REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: CLEAVED ALPHA1-ANTITRYPSIN (PDB ENTRY 9API) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG, 0.2 M SODIUM ACETATE, 0.1 M REMARK 280 TRIS.HCL, PH 6.0, 0.002 M FESO4, 25 DEG CELSIUS REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.47900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.25400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.47900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.25400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 THR A 11 REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 465 HIS A 20 REMARK 465 PRO A 21 REMARK 465 THR A 22 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 PRO A 106 REMARK 475 ASP A 107 REMARK 475 SER A 108 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 25 -50.65 -146.43 REMARK 500 GLN A 44 -73.77 -45.42 REMARK 500 SER A 47 56.24 -115.51 REMARK 500 ALA A 70 -146.37 47.92 REMARK 500 PRO A 106 -155.45 -63.73 REMARK 500 SER A 108 142.12 165.45 REMARK 500 GLN A 111 105.96 -56.90 REMARK 500 LYS A 136 -77.48 -68.35 REMARK 500 HIS A 139 41.83 39.74 REMARK 500 ASP A 149 78.64 -106.37 REMARK 500 ASP A 171 69.49 34.99 REMARK 500 LYS A 191 76.34 -163.49 REMARK 500 HIS A 209 99.14 -67.35 REMARK 500 ASN A 247 28.20 -165.51 REMARK 500 ASP A 256 -176.72 -63.27 REMARK 500 LEU A 318 45.00 -109.36 REMARK 500 ASP A 341 -157.85 -147.58 REMARK 500 LYS A 343 98.86 169.67 REMARK 500 ALA A 347 -158.26 -149.07 REMARK 500 ALA A 348 87.83 -53.91 REMARK 500 ALA A 350 100.94 56.59 REMARK 500 SER A 359 140.22 -179.15 REMARK 500 ILE A 360 101.97 -53.90 REMARK 500 REMARK 500 REMARK: NULL DBREF 1PSI A 2 394 UNP P01009 A1AT_HUMAN 26 418 SEQADV 1PSI LEU A 51 UNP P01009 PHE 75 ENGINEERED MUTATION SEQRES 1 A 394 MET ASP PRO GLN GLY ASP ALA ALA GLN LYS THR ASP THR SEQRES 2 A 394 SER HIS HIS ASP GLN ASP HIS PRO THR PHE ASN LYS ILE SEQRES 3 A 394 THR PRO ASN LEU ALA GLU PHE ALA PHE SER LEU TYR ARG SEQRES 4 A 394 GLN LEU ALA HIS GLN SER ASN SER THR ASN ILE LEU PHE SEQRES 5 A 394 SER PRO VAL SER ILE ALA THR ALA PHE ALA MET LEU SER SEQRES 6 A 394 LEU GLY THR LYS ALA ASP THR HIS ASP GLU ILE LEU GLU SEQRES 7 A 394 GLY LEU ASN PHE ASN LEU THR GLU ILE PRO GLU ALA GLN SEQRES 8 A 394 ILE HIS GLU GLY PHE GLN GLU LEU LEU ARG THR LEU ASN SEQRES 9 A 394 GLN PRO ASP SER GLN LEU GLN LEU THR THR GLY ASN GLY SEQRES 10 A 394 LEU PHE LEU SER GLU GLY LEU LYS LEU VAL ASP LYS PHE SEQRES 11 A 394 LEU GLU ASP VAL LYS LYS LEU TYR HIS SER GLU ALA PHE SEQRES 12 A 394 THR VAL ASN PHE GLY ASP THR GLU GLU ALA LYS LYS GLN SEQRES 13 A 394 ILE ASN ASP TYR VAL GLU LYS GLY THR GLN GLY LYS ILE SEQRES 14 A 394 VAL ASP LEU VAL LYS GLU LEU ASP ARG ASP THR VAL PHE SEQRES 15 A 394 ALA LEU VAL ASN TYR ILE PHE PHE LYS GLY LYS TRP GLU SEQRES 16 A 394 ARG PRO PHE GLU VAL LYS ASP THR GLU GLU GLU ASP PHE SEQRES 17 A 394 HIS VAL ASP GLN VAL THR THR VAL LYS VAL PRO MET MET SEQRES 18 A 394 LYS ARG LEU GLY MET PHE ASN ILE GLN HIS SCS LYS LYS SEQRES 19 A 394 LEU SER SER TRP VAL LEU LEU MET LYS TYR LEU GLY ASN SEQRES 20 A 394 ALA THR ALA ILE PHE PHE LEU PRO ASP GLU GLY LYS LEU SEQRES 21 A 394 GLN HIS LEU GLU ASN GLU LEU THR HIS ASP ILE ILE THR SEQRES 22 A 394 LYS PHE LEU GLU ASN GLU ASP ARG ARG SER ALA SER LEU SEQRES 23 A 394 HIS LEU PRO LYS LEU SER ILE THR GLY THR TYR ASP LEU SEQRES 24 A 394 LYS SER VAL LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SEQRES 25 A 394 SER ASN GLY ALA ASP LEU SER GLY VAL THR GLU GLU ALA SEQRES 26 A 394 PRO LEU LYS LEU SER LYS ALA VAL HIS LYS ALA VAL LEU SEQRES 27 A 394 THR ILE ASP GLU LYS GLY THR GLU ALA ALA GLY ALA MET SEQRES 28 A 394 PHE LEU GLU ALA ILE PRO MET SER ILE PRO PRO GLU VAL SEQRES 29 A 394 LYS PHE ASN LYS PRO PHE VAL PHE LEU MET ILE GLU GLN SEQRES 30 A 394 ASN THR LYS SER PRO LEU PHE MET GLY LYS VAL VAL ASN SEQRES 31 A 394 PRO THR GLN LYS MODRES 1PSI SCS A 232 CYS 3-(ETHYLDISULFANYL)-L-ALANINE HET SCS A 232 9 HETNAM SCS 3-(ETHYLDISULFANYL)-L-ALANINE FORMUL 1 SCS C5 H11 N O2 S2 HELIX 1 1 THR A 27 GLN A 44 1 18 HELIX 2 2 PRO A 54 GLY A 67 1 14 HELIX 3 3 ALA A 70 GLY A 79 1 10 HELIX 4 4 GLU A 89 ASN A 104 1 16 HELIX 5 5 ASP A 128 LYS A 135 1 8 HELIX 6 6 THR A 150 GLY A 164 1 15 HELIX 7 7 VAL A 200 ASP A 202 5 3 HELIX 8 8 LEU A 260 GLU A 266 1 7 HELIX 9 9 HIS A 269 LEU A 276 1 8 HELIX 10 10 LEU A 299 GLN A 305 1 7 HELIX 11 11 LYS A 310 PHE A 312 5 3 SHEET 1 A 5 ILE A 50 PHE A 52 0 SHEET 2 A 5 PRO A 382 VAL A 388 -1 N LYS A 387 O ILE A 50 SHEET 3 A 5 PHE A 370 GLU A 376 -1 N MET A 374 O LEU A 383 SHEET 4 A 5 ALA A 248 PRO A 255 -1 N PHE A 253 O VAL A 371 SHEET 5 A 5 SER A 237 LYS A 243 -1 N MET A 242 O ALA A 250 SHEET 1 B 5 GLU A 141 VAL A 145 0 SHEET 2 B 5 LEU A 112 SER A 121 1 N LEU A 118 O GLU A 141 SHEET 3 B 5 PHE A 182 PHE A 190 -1 N PHE A 189 O THR A 113 SHEET 4 B 5 LYS A 331 ILE A 340 1 N LYS A 331 O LEU A 184 SHEET 5 B 5 LEU A 291 ASP A 298 -1 N TYR A 297 O HIS A 334 SHEET 1 C 4 GLU A 204 HIS A 209 0 SHEET 2 C 4 THR A 215 PHE A 227 -1 N MET A 220 O GLU A 204 SHEET 3 C 4 ARG A 282 PRO A 289 -1 N LEU A 288 O MET A 221 SHEET 4 C 4 PRO A 362 PHE A 366 1 N PRO A 362 O SER A 285 LINK C HIS A 231 N SCS A 232 1555 1555 1.32 LINK C SCS A 232 N LYS A 233 1555 1555 1.33 CRYST1 112.958 38.508 88.928 90.00 104.85 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008853 0.000000 0.002347 0.00000 SCALE2 0.000000 0.025969 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011634 0.00000